Switzerland-based cryptocurrency firm 21Shares is betting on proof-of-stake (PoS) coins by launching a new crypto exchange-traded product (ETP) dedicated to staking.
21Shares on Jan. 18 launched the 21Shares Staking Basket Index ETP, a crypto staking index designed to track up to 10 PoS cryptocurrencies. The ETP immediately starts trading on the local stock exchange BX Swiss under the ticker STAKE.
At launch, 21Shares’ STAKE ETP tracks six digital assets, including Binance Coin (BNB), Cardano (ADA), Cosmos (ATOM), Polkadot (DOT), Solana (SOL) and Tezos (XTZ). The index will rebalance on a semi-annual basis in March and September in accordance with market shifts.
With addition of STAKE, 21Shares and its parent firm 21.co now provide a total of 47 crypto ETP products across 12 exchanges in nine countries. The ETPs aim to provide investors with a safe and secure way to gain exposure to crypto, offering an alternative to direct crypto investment.
“STAKE provides value for investors by using the ETP’s assets to generate a passive yield that may offer additional returns by contributing to the network’s security,” 21.co director of ETP Arthur Krause said in a statement to Cointelegraph.
The launch of STAKE ETP comes a few years after 21Shares started experimenting with staking ETPs. In 2019, 21Shares debuted the 21Shares Tezos Staking ETP (AXTZ) and then launched the 21Shares Solana Staking ETP (ASOL) in June 2021.
Both products experienced a significant decline in 2022, which came in line with a massive bear market in crypto last year. On the other hand, the ETPs have been growing so far in 2023 with year-to-date performance surging 38% for AXTZ, and 78% for ASOL.
Related: Ethereum founder says he hopes Solana gets a ‘chance to thrive’
Krause emphasized that assets like Solana — which is widely linked to the collapsed FTX exchange — have not had any impact on 21Shares’ products, stating:
“Solana — like virtually all other crypto assets — experienced significant price declines in 2022 but suffered no fundamental impairment that would preclude its…..